Dr Xand discussed recent headlines about prostate cancer, what you should look out for and when to speak to a GP.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...

Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...

The disease has been in the headlines over recent years after Olympian Sir Chris Hoy was diagnosed with the cancer. Former ...

Olympic legend Sir Chris Hoy says ‘we need more men to be diagnosed with prostate cancer early to stop them getting news I ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Prostate Cancer UK said a 42 per cent rise in diagnoses in the past decade is thanks to increased awareness of the disease by ...